Search Within

Genitourinary Oncology Service

  1. "Cancer Investigation"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (11)
  2. Solid Tumor Oncology Division (11)
  3. Hematologic Malignancies, Division of (2)
  4. Surgery (2)
  5. Survivorship Research (2)
  6. Urology (2)

More Groups

People
  1. Howard Scher (4)
  2. Dean Bajorin (3)
  3. Geralyn Higgins (2)
  4. Harry Herr (2)
  5. John McCaffrey (2)
  6. Madhu Mazumdar (2)

More People

Years
  1. 2021 (1)
  2. 2016 (1)
  3. 2004 (1)
  4. 2003 (1)
  5. 2000 (2)
  6. 1997 (1)

More Years

Publications
  1. Cancer Investigation (11)
Publishers
  1. Informa Healthcare (11)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association between site-of-care and the cost and modality of radiotherapy for prostate cancer: Analysis of Medicare beneficiaries from 2015 to 2017
    Journal Article

    Tringale, K. R.; Gennarelli, R. L.; Gillespie, E. F.; Mitchell, A. P.; Zelefsky, M. J.
    Cancer Investigation (2021)

    Fulltext@MSK | Save
  • Tumor inhibition by enzalutamide in a xenograft model of ovarian cancer
    Journal Article

    Park, B. Y.; Grisham, R. N.; den Hollander, B.; Thapi, D.; Berman, T.; de Stanchina, E.; Zhou, Q.; Iyer, G.; Aghajanian, C.; Spriggs, D. R.
    Cancer Investigation (2016)

    Fulltext@MSK | Save
  • Chemotherapeutic response with single agent gemcitabine in metastatic bellini duct tumor
    Journal Article

    Slovin, S. F.; Berg, W.; Olgac, S.; Reuter, V.; Scher, H.
    Cancer Investigation (2004)

    Fulltext@MSK | Save
  • Dendritic cell vaccines - Hopeful or hopeless?
    Journal Article

    Slovin, S. F.
    Cancer Investigation (2003)

    Fulltext@MSK | Save
  • Ifosfamide, paclitaxel, and cisplatin (ITP) in urothelial cancer: The Memorial Sloan-Kettering Cancer Center experience with ITP as a single regimen and preceded by doxorubicin and gemcitabine (AG) in a dose-dense sequenced approach
    Meeting Abstract

    Bajorin, D. F.; McCaffrey, J. A.; Dodd, P.; Hilton, S.; Mazumdar, M.; Donat, S.; Herr, H.; Higgins, G.
    Cancer Investigation (2000)

    Fulltext@MSK | Save
  • Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancer
    Journal Article

    Dodd, P. M.; Mccaffrey, J. A.; Mazumdar, M.; Scher, H.; Higgins, G.; Boyle, M. G.; Herr, H.; Bajorin, D. F.
    Cancer Investigation (2000)

    Fulltext@MSK | Save
  • Evaluation of chemotherapy and radiation enhancement and (31)P NMR spectral changes induced by biochemical modulation
    Journal Article

    Koutcher, J. A.; Alfieri, A. A.; Tsai, J. C.; Matei, C.; Stolfi, R. L.; Ballon, D.; Martin, D. S.
    Cancer Investigation (1997)

    Fulltext@MSK | Save
  • The current status of salvage chemotherapy for patients with cisplatin-resistant germ cell tumors
    Journal Article

    Motzer, R. J.; Bosl, G. J.
    Cancer Investigation (1993)

    Fulltext@MSK | Save
  • A phase I trial of combination chemotherapy employing carboplatin, vinca alkaloids, with or without bleomycin in patients with advanced malignant tumors
    Journal Article

    Bajorin, D.; Kelsen, D. P.
    Cancer Investigation (1990)

    Fulltext@MSK | Save
  • Controversies in treatment of small cell carcinoma of the lung
    Journal Article

    Shank, B.; Scher, H. I.
    Cancer Investigation (1985)

    Fulltext@MSK | Save